Furthermore, the engineered bacterium DB1 designed by Rong et al. induces tertiary lymphoid structure (TLS) maturation via the IL-10 signaling axis, promotes CD8+ T cell activation and infiltration, and significantly inhibits tumor growth in colon cancer and melanoma models. The gene discussed is CD8A; the disease is neoplasm.